66357 results
-
List item
Human medicine European public assessment report (EPAR): Ebymect (updated)
dapagliflozin propanediol monohydrate, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 15/11/2015, Revision: 16, Authorised, Last updated: 24/02/2021 -
List item
Human medicine European public assessment report (EPAR): Prepandrix (updated)
A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2), Influenza, Human, Immunization, Disease Outbreaks
Date of authorisation: 14/05/2008,
, Revision: 13, Withdrawn, Last updated: 23/02/2021
-
List item
Human medicine European public assessment report (EPAR): Januvia (updated)
sitagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 20/03/2007, Revision: 28, Authorised, Last updated: 23/02/2021 -
List item
Human medicine European public assessment report (EPAR): Remsima (updated)
infliximab, Arthritis, Psoriatic, Spondylitis, Ankylosing, Colitis, Ulcerative, Psoriasis, Crohn Disease, Arthritis, Rheumatoid
Date of authorisation: 10/09/2013,
, Revision: 22, Authorised, Last updated: 23/02/2021
-
List item
Human medicine European public assessment report (EPAR): Galafold (updated)
migalastat hydrochloride, Fabry Disease
Date of authorisation: 25/05/2016,
, 
, Revision: 11, Authorised, Last updated: 23/02/2021
-
List item
Veterinary medicine European public assessment report (EPAR): Locatim (previously Serinucoli) (updated)
Bovine concentrated lactoserum containing specific immunoglobulins G against E. coli F5 (K99) adhesin, Calves, neonatal less than 12 hrs of age
Date of authorisation: 29/03/1999, Revision: 13, Authorised, Last updated: 23/02/2021 -
List item
Human medicine European public assessment report (EPAR): Hycamtin (updated)
topotecan, Ovarian Neoplasms, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma
Date of authorisation: 12/11/1996, Revision: 32, Authorised, Last updated: 23/02/2021 -
List item
Human medicine European public assessment report (EPAR): Tecentriq (updated)
atezolizumab, Carcinoma, Transitional Cell, Carcinoma, Non-Small-Cell Lung, Urologic Neoplasms, Breast Neoplasms, Small Cell Lung Carcinoma
Date of authorisation: 20/09/2017,, Revision: 12, Authorised, Last updated: 23/02/2021
-
List item
Human medicine European public assessment report (EPAR): Benepali (updated)
etanercept, Arthritis, Psoriatic, Arthritis, Rheumatoid, Psoriasis
Date of authorisation: 13/01/2016,, Revision: 13, Authorised, Last updated: 23/02/2021
-
List item
Human medicine European public assessment report (EPAR): Luveris (updated)
lutropin alfa, Ovulation Induction, Infertility, Female
Date of authorisation: 29/11/2000, Revision: 20, Authorised, Last updated: 23/02/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Halocur (updated)
halofuginone, Calves, newborn
Date of authorisation: 29/10/1999, Revision: 9, Authorised, Last updated: 23/02/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Posatex (updated)
orbifloxacin, Mometasone furoate, posaconazole, Dogs
Date of authorisation: 23/06/2008, Revision: 9, Authorised, Last updated: 23/02/2021 -
List item
Human medicine European public assessment report (EPAR): Idelvion (updated)
albutrepenonacog alfa, Hemophilia B
Date of authorisation: 11/05/2016,, , Revision: 9, Authorised, Last updated: 23/02/2021
-
List item
Human medicine European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka d.d. (updated)
emtricitabine, tenofovir disoproxil succinate, HIV Infections
Date of authorisation: 28/04/2017,
, Revision: 7, Authorised, Last updated: 22/02/2021
-
List item
Human medicine European public assessment report (EPAR): Levetiracetam ratiopharm (updated)
levetiracetam, Epilepsy
Date of authorisation: 26/08/2011,, Revision: 11, Authorised, Last updated: 22/02/2021
-
List item
Veterinary medicine European public assessment report (EPAR): Suvaxyn Aujeszky 783 + O/W (updated)
live attenuated Aujeszky's disease virus, Pigs
Date of authorisation: 07/08/1998, Revision: 15, Authorised, Last updated: 22/02/2021 -
List item
Human medicine European public assessment report (EPAR): Xydalba (updated)
dalbavancin hydrochloride, Soft Tissue Infections, Skin Diseases, Bacterial
Date of authorisation: 19/02/2015, Revision: 12, Authorised, Last updated: 22/02/2021 -
List item
Human medicine European public assessment report (EPAR): Arixtra (updated)
fondaparinux sodium, Venous Thrombosis, Pulmonary Embolism, Myocardial Infarction, Angina, Unstable
Date of authorisation: 20/03/2002, Revision: 30, Authorised, Last updated: 22/02/2021 -
List item
Human medicine European public assessment report (EPAR): Nepexto (updated)
etanercept, Arthritis, Rheumatoid, Arthritis, Juvenile Rheumatoid, Arthritis, Psoriatic, Spondylarthropathies, Spondylitis, Ankylosing, Psoriasis
Date of authorisation: 20/05/2020,, , Revision: 3, Authorised, Last updated: 22/02/2021
-
List item
Human medicine European public assessment report (EPAR): Kanjinti (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 16/05/2018,, , Revision: 7, Authorised, Last updated: 22/02/2021
-
List item
Human medicine European public assessment report (EPAR): Edurant (updated)
rilpivirine hydrochloride, HIV Infections
Date of authorisation: 28/11/2011, Revision: 18, Authorised, Last updated: 22/02/2021 -
List item
Human medicine European public assessment report (EPAR): Spinraza (updated)
nusinersen sodium, Muscular Atrophy, Spinal
Date of authorisation: 30/05/2017,, , , Revision: 11, Authorised, Last updated: 22/02/2021
-
List item
Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva (updated)
efavirenz, emtricitabine, tenofovir disoproxil phosphate, HIV Infections
Date of authorisation: 17/07/2017,, Revision: 6, Authorised, Last updated: 22/02/2021
-
List item
Veterinary medicine European public assessment report (EPAR): Innovax-ILT (updated)
Cell-associated live recombinant turkey herpesvirus (strain HVT/ILT-138), expressing the glycoproteins gD and gI of infectious laryngotracheitis virus, Chicken
Date of authorisation: 03/07/2015, Revision: 3, Authorised, Last updated: 22/02/2021 -
List item
Human medicine European public assessment report (EPAR): Besremi (updated)
ropeginterferon alfa-2b, Polycythemia Vera
Date of authorisation: 15/02/2019,, Revision: 1, Authorised, Last updated: 22/02/2021